Michelle Yaolin Cheng

Michelle Cheng practices at Sunnyvale Center in Sunnyvale, California.

Michelle Cheng's NPI, 1467871590, was assigned on April 16, 2014. Michelle Cheng graduated from University of Pittsburgh School of Medicine in 2014. Michelle Cheng holds California license A137986.

Michelle Cheng's primary practice is Sunnyvale Center, at 401 Old San Francisco Rd, 2nd Fl, Sunnyvale, CA 94086. The practice phone is (408) 730-6227.

Michelle Cheng's primary practice is Sunnyvale Center in Sunnyvale, California. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Michelle Cheng to 1 more group practice or clinic and 1 medical group, each named with a free account. Michelle Cheng's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Michelle Cheng practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Michelle Cheng's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Michelle Cheng is board certified in dermatology by the American Board of Dermatology. Dmand AI has Michelle Cheng's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives, itchy rashes, joint cyst and minor injury on trunk among the conditions Michelle Cheng treats.

CMS data shows 2,890 Medicare services from Michelle Cheng across 14 procedure codes in 2024, for 516 Medicare patients. Medicare paid $130,800 for them. Every service was in an office.

CMS counts 516 Medicare patients who saw Michelle Cheng in 2024. The largest group is 65 to 74, with 241 patients. 72% of them have high cholesterol, and 60% have high blood pressure. 6% are also on Medicaid. Their average risk score is 0.84, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michelle Cheng's median patient age at 55, with 56% women.

In 2024, Michelle Cheng wrote 706 Medicare Part D claims for 240 patients. 90% of them were for generic drugs. CMS names the drug for 569 of them, across 16 drugs with 11 or more claims each, at $219,431 in total drug cost. In 2023, CMS named 520 claims across 13 drugs.

Michelle Cheng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 796 procedures of removal of skin lesions by Michelle Cheng, more than 91% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 48 papers to Michelle Cheng, published from 2012 to 2024. 2019 was the busiest year, with 9. The most frequent topics are Melanoma, Skin Neoplasms and Pyoderma Gangrenosum. Michelle Cheng has published most often in JAMA Dermatol. Michelle Cheng's most frequent co-authors are Emanual Michael Maverakis, MD, Chelsea Ma, MD and Elizabeth Wang, MD.

CMS Open Payments shows 188 general payments to Michelle Cheng from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,930. It also lists 7 research payments totaling $1,261 in 2016.

Michelle Cheng graduated from University of Pittsburgh School of Medicine in 2014.

Michelle Cheng is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.